RPAM
AIMT

Rhenman & Partners Asset Management’s Aimmune Therapeutics AIMT Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$4.76M Buy
2020
Q1 		$2.38M Buy
2019
Q4 		$5.02M Buy
2019
Q3 		$3.12M Hold
2019
Q2 		$3.11M Hold
2019
Q1 		$3.33M Buy